Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.
Entera Bio (ENTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL injection for ...
Ecopipam, Emalex's investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late- ...
Background Understanding drivers of high healthcare utilisation costs among individuals experiencing first-episode psychosis ...
Scientists have developed a new type of semiconductor material that can do something unusual: it can tell the difference ...
Tests promising to reveal your “biological age” are booming. But scientists say the results vary widely — and aren’t reliable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results